1. Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. 2008; Прил. 2.
2. Kaplan N, Opie LH. Antihypertensive drugs. Ed.: L.Opie, Drugs for the heart, 4th ed. Philadelphia: W.B. Saunders, 1995.
3. Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994; 154 (13): 1461–8.
4. Frishman WH, Burris JF, Mroczek WJ et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35 (2): 182–8.
5. Prisant LM, Neutel JM, Papademetriou V et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998; 5: 313–21.
6. Benetos A, Adamopoulos C, Argyriadis P et al. Clinical results with bisoprolol 2,5 mg/hydrochlorothiazide 6,25 mg combination in systolic hypertension in the elderly. Hypertens Suppl 2002; 20 (1): 21–5.
Авторы
Л.Г.Ратова, И. Е.Чазова
ФГУ РКНПК Федерального агентства по высокотехнологичной медицинской помощи, Москва